Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 3, 2009

NEW YORK (GenomeWeb News) - Qiang Zhang has been named director of the Hamner Center for Dose Response Modeling at the Hamner Institutes for Health Sciences. In this position, Zhang will lead the center's systems biology efforts to understand non-linear biological response networks and to develop computational methodologies for understanding cellular pathways and toxic response.

Zhang was a post-doctoral researcher at the Hamner Institute for Health Sciences from 2003 to 2006, and after that he was promoted to research investigator.


Christopher Ahlberg has joined Fina Technologies' board of directors. Ahlberg, a founder and former CEO of Spotfire, also serves on the board of directors at Apptus Technologies AB and the Hult International Business School. He also was executive VP of Tibco and president of Tibco's Spotfire division.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.